New Meningitis Vaccines available at Stamps Health Services

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Dr. Gregory Moore, Senior Director, Stamps Health Services

Contact
No contact information submitted.
Sidebar Content
No sidebar content submitted.
Summaries

Summary Sentence:

A new meningitis vaccine is now available at Stamps Health Services.

Full Summary:

No summary paragraph submitted.

Even though there have been no recently reported cases of meningitis at Georgia Tech, meningitis did make news during the past year due to outbreaks at other college campuses across the United States.

Meningitis, specifically meningococcal meningitis, is a rare but serious and potentially fatal disease. There has long been a vaccine (MCV4) available that can prevent meningitis caused by Serogroups A, C, Y and W.

The MCV4 vaccine has also long been required for Georgia Tech students because college age young adults are at a higher risk of meningococcal meningitis than other age groups.

 

New Vaccines Available for MenB Meningitis

MenB causes approximately one-third of the bacterial meningitis cases in the United States and until recently, there was no vaccine available. Newly developed vaccines against Serogroup B (MenB) have recently been approved by the FDA (U.S. Food & Drug Administration).

The Centers for Disease Control and Prevention (CDC) recently announced its recommendation for the MenB vaccine series:

  • The MenB Vaccine maybe administered to adolescents and young adults ages 16 through 23 to provide short-term protection against most strains of Serogroup B meningococcal disease.
  • The preferred age for vaccination is 16 through 18 years.
  • It is strongly recommended for individuals at particularly high risk.

While MenB vaccine is not currently required at Georgia Tech, it is recommended and available. Costs for the meningitis vaccines are determined by which series the student receives and whether the entire series is administered at Georgia Tech or if the student only needs one shot to complete the series.

More about Meningitis

Pfizer (distributor one of the meningitis vaccines) has developed a video of a student describing his experience with meningitis at https://www.facebook.com/MeetMeningitis/videos/994367453909911/

 

For more information on meningitis and the meningitis vaccines, visit the CDC website http://www.cdc.gov/meningitis/index.html or contact Stamps Health Services Immunization Clinic http://health.gatech.edu/immunization/Pages/default.aspx or email

debbie.spillers@health.gatech.edu

Additional Information

Groups

Parent and Family Programs

Categories
No categories were selected.
Related Core Research Areas
No core research areas were selected.
Newsroom Topics
No newsroom topics were selected.
Keywords
No keywords were submitted.
Status
  • Created By: Sara Warner
  • Workflow Status: Published
  • Created On: Jul 29, 2015 - 11:22am
  • Last Updated: Oct 7, 2016 - 11:19pm